| In a 90 minute Roundtable session, the first
rotation uses the first 45 minutes and the second rotation uses the last 45 minutes.
|
| Roundtable Rotation I:
Monitoring and Evaluation Following a Harm Reduction Philosophy |
|
Roundtable Presentation 211 to be held in Conference Room 12 on Thursday, Nov 3, 8:00 AM to 9:30 AM
|
|
Sponsored by the Health Evaluation TIG
|
| Presenter(s):
|
| Adam Viera, Harm Reduction Coalition, viera@harmreduction.org
|
| Abstract:
Monitoring and evaluation are undoubtedly critical elements of successful public health programming. However, there exists little understanding around how to develop a process and outcome monitoring and evaluation infrastructure that is reflective of harm reduction principles and interventions. There is a need for a monitoring and evaluation framework that is reflective of the harm reduction philosophy at all levels.
The facilitators will lead a discussion around the principles undergirding a harm reduction framework for monitoring and evaluation. This discussion will transition into a discussion of best practices for harm reduction monitoring and evaluation, as well as next steps for continued dialogue around this important issue.
|
| Roundtable Rotation II:
Program Evaluation Activities in Tuberculosis Control Programs in the United States: The Value of Conducting a Large-scale Assessment |
|
Roundtable Presentation 211 to be held in Conference Room 12 on Thursday, Nov 3, 8:00 AM to 9:30 AM
|
|
Sponsored by the Health Evaluation TIG
|
| Presenter(s):
|
| Silvia Trigoso, Centers for Disease Control and Prevention, strigoso@cdc.gov
|
| Abstract:
The Centers for Disease Control and Prevention, Division of Tuberculosis Elimination supports grantees with evaluation technical assistance (TA) and consultation to strengthen evaluation capacity among tuberculosis (TB) control and prevention programs. Assessment of current status, progress, and challenges in implementing program evaluation (PE) activities provides valuable information and guidance for grantees, stakeholders, and decision-makers. This presentation focuses on the process to review evaluation plan development, proposed evaluation activities, and progress reports for 68 grantees (50 states, 10 big cities, and 8 islands/territories) submitted for the 2010-2014 funding cycle. The design, method, and tools used to evaluate an array of evaluation plans from TB control programs of varying evaluation capacity and financial constraints will be described. Challenges and lessons learned, translatable to other disciplines and public health programs, will be shared. The result of this large-scale assessment provides an opportunity to shape decisions, enhance TA, and expand grantee's evaluation capacity.
|